Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AS900672-Enriched vs GONAL-f for ovulation induction in oligo-anovulatory infertile women
2007-002823-34Phase 2Terminated
- Sponsor
- Merck Serono
- Start
- Sep 2007
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial of AS900672 in infertility (2 arms), sponsored by Merck Serono. Primary endpoint: Ovulation rate. Started Sep 2007; status: terminated.
02
Drugs
AS900672
03
Conditions
infertility
Beyond the preview
Go deeper on 2007-002823-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-002823-34.